Journal of Neuro-Oncology

High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictors.  158:33-40. 2022

Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy.  156:163-172. 2022

Mitochondrial DNA sequence variation and risk of meningioma.  155:319-324. 2021

Impact of brain metastasis velocity on neurologic death for brain metastasis patients experiencing distant brain failure after initial stereotactic radiosurgery.  146:285-292. 2020

Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis.  141:289-301. 2019

Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study.  140:341-349. 2018

UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.  140:209-224. 2018

Initial brain metastasis velocity: does the rate at which cancers first seed the brain affect outcomes?.  139:461-467. 2018

Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?.  138:163-171. 2018

Handedness and the risk of glioma.  137:639-644. 2018

Increasing time to postoperative stereotactic radiation therapy for patients with resected brain metastases: investigating clinical outcomes and identifying predictors associated with time to initiation.  136:545-553. 2018

Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram.  135:403-411. 2017

Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.  133:277-285. 2017

Key rates for the grades and transformation ability of glioma: model simulations and clinical cases.  133:377-388. 2017

Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells.  132:219-229. 2017

A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.  129:487-494. 2016

A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas.  129:139-146. 2016

What predicts early volumetric edema increase following stereotactic radiosurgery for brain metastases?.  127:303-311. 2016

Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas.  125:123-131. 2015

Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas.  122:585-593. 2015

Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters.  120:361-370. 2014

Cognition in patients with newly diagnosed brain metastasis: Profiles and implications.  120:179-185. 2014

CXCL12 secreted from glioma stem cells regulates their proliferation.  117:43-51. 2014

Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro.  118:61-72. 2014

Reproductive factors and risk of primary brain tumors in women.  118:297-304. 2014

Prediagnostic body weight and survival in high grade glioma.  114:79-84. 2013

Mutant tristetraprolin: A potent inhibitor of malignant glioma cell growth.  113:195-205. 2013

The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer.  112:467-472. 2013

Stereotactic radiosurgical treatment of brain metastasis of primary tumors that rarely metastasize to the central nervous system.  109:513-519. 2012

A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma.  105:639-646. 2011

Phase i and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas.  105:375-381. 2011

L1 stimulation of human glioma cell motility correlates with FAK activation.  105:27-44. 2011

Erratum: Cancer susceptibility variants and the risk of adult glioma in a US case-control study (Journal of Neuro-Oncology DOI: 10.1007/s11060-010-0506-0).  104:543. 2011

An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas.  102:367-381. 2011

Cancer susceptibility variants and the risk of adult glioma in a US case-control study.  104:535-542. 2011

Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: Results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma.  101:57-66. 2011

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme.  101:179-188. 2011

Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma.  100:95-103. 2010

Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth.  99:177-185. 2010

Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111.  95:199-209. 2009

Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness.  85:271-280. 2007

Long-term outcome of patients with intracranial germinoma.  83:71-79. 2007

Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM).  80:261-274. 2006

1p/19q chromosome deletions in metastatic oligodendroglioma.  80:203-207. 2006

Radiation dosimetry of ¹³¹I-chlorotoxin for targeted radiotherapy in glioma-bearing mice.  71:113-119. 2005

Genetic and hypoxic regulation of angiogenesis in gliomas.  70:229-243. 2004

Caspase-1 mediates Fas-induced apoptosis and is up-regulated by interferon-γ in human astrocytoma cells.  67:167-176. 2004

Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line.  66:273-284. 2004

Oncolytic viruses: Clinical applications as vectors for the treatment of malignant gliomas.  65:203-226. 2003

High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma.  65:127-134. 2003

Fas engagement increases expression of interleukin-6 in human glioma cells.  56:13-19. 2002

Immunotherapy of a murine T cell lymphoma localized to the brain.  47:1-10. 2000

Adenoid cystic carcinoma metastatic to the dura: Report of two cases.  44:267-273. 1999

Intraoperative cortical mapping as a guide to the surgical resection of gliomas.  42:233-245. 1999

Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion.  41:9-20. 1999

Fabrication and testing of a device capable of reducing the incidence of ventricular shunt promoted metastasis..  27:39-46. 1996

Expression of the CD44 adhesion molecule in tumours of the central and peripheral nervous system.  26:191-198. 1995

Multiple fraction-per-day radiotherapy for patients with brain stem tumors.  17:131-138. 1993

Human glioblastoma cells produce 77 amino acid interleukin-8 (IL-877).  16:25-34. 1993

Medulloblastoma: tumor biological and clinical perspectives.  11:1-15. 1991

The chemotherapy of posterior Fossa tumors in childhood.  5:217-229. 1987